Active-ingredient Dossier

Plerixafor

Active-ingredient Dossier for Plerixafor (bicyclam chemokine receptor antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: PLERIXAFOR
Brand: MOZOBIL
Brand: PLERIXAFOR
Brand: Plerixafor-AFT
Brand: EUG-PLERIXAFOR
Therapeutic area: Haematology

What is

Plerixafor Plerixafor is a bicyclam chemokine receptor antagonist.

Australian brands containing

Plerixafor — PLERIXAFOR — MOZOBIL — Plerixafor-AFT — EUG-PLERIXAFOR

Therapeutic areas

Plerixafor is registered in oncology, with five brands containing this ingredient on the ARTG.

Sponsor landscape

Plerixafor is marketed by four sponsors: Eugia Pharma, Sanofi-Aventis, Arrotex Pharmaceuticals, and AFT Pharmaceuticals.

PBS and regulatory activity

One brand containing plerixafor has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2013, and no AusPARs have been recorded for plerixafor.